Floatz logo

253 assets in Diffuse Large B-Cell Lymphoma

Therapeutic assets addressing Diffuse Large B-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
br1733
Diffuse Large B-Cell Lymphoma
Shanghai Blueray Biopharma Co., Ltd.P1/2CC (43)
c402-cd19-car
Diffuse Large B-Cell Lymphoma
Shanghai Exuma Biotechnology Ltd.P1CC (43)
c7r.cd30.car-ebvst cells
Diffuse Large B-Cell Lymphoma
Baylor College of MedicineP1CC (43)
Car-Nk-Cd19 Cells
Diffuse Large B-Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
cd19-car_lenti t cell
Diffuse Large B-Cell Lymphoma
Bambino Gesù Hospital and Research InstituteP1/2CC (43)
cd19 specific chimeric antigen receptor t cell
Diffuse Large B-Cell Lymphoma
Pell Bio-Med Technology Co., Ltd.P1/2CC (43)
cd19-ucart
Diffuse Large B-Cell Lymphoma
Chongqing Precision Biotech Co., LtdP1/2CC (43)
cd22 car-transduced t cells
Diffuse Large B-Cell Lymphoma
Essen BiotechP1/2CC (43)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
Diffuse Large B-Cell Lymphoma
First Affiliated Hospital of Zhejiang UniversityP1/2CC (43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Diffuse Large B-Cell Lymphoma
Roswell Park Cancer InstituteP1CC (43)
Enzalutamide
Diffuse Large B-Cell Lymphoma
Novartis PharmaceuticalsP1/2CC (43)
exs73565
Diffuse Large B-Cell Lymphoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (43)
Fruquintinib
Diffuse Large B-Cell Lymphoma
Immunitas TherapeuticsP1/2CC (43)
Gamma4 Heavy Chain Homo Sapiens (1-446) [Vh (Homo Sapiens Ighv4-39*01 (96.0%) -(Ighd) -Ighj3*02 (100%), Cdr-Imgt [10.7.12] (26-35.53-59.98-109)) (1-120)-Homo Sapiens Ighg4*01, Ng4M(A) Ch2 L92, G4V5 H P10, G4V4 Ch2 A1.3, A1.2 (Ch1 (121-218), Hinge 1-12 S10>P (228) (219-230), Ch2 F1.3>A (234), L1.2>A (235), L92 (309) (231-340), Ch3 (341-445), Chs K2>Del (446)) (121-446)], (134-215')-Disulfide With Kappa Light Chain Homo Sapiens (1'-215') [V-Kappa (Homo Sapiens Igkv1-33*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt[6.3.10] (27'-32'.50'-52'.89'-98')) (1'-108') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (154'), V101 (192') (109'-215')], Dimer (226-226'':229-229'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho)-K1Sv Cell Line Lacking The Glutamine Synthetase Gene (Gs-Ko), Glycoform Alfa
Diffuse Large B-Cell Lymphoma
Innovent Biologics (Suzhou) Co. Ltd.P1CC (43)
Gnc-038
Diffuse Large B-Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.P1/2CC (43)
Hmpl-760
Diffuse Large B-Cell Lymphoma
HutchmedP1CC (43)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Klrb1 (Killer Cell Lectin Like Receptor B1, Nkr-P1A, Natural Killer Cell Surface Protein P1A, Clec5B, Cd161)], Homo Sapiens Monoclonal Antibody; Gamma1 Heavy Chain Homo Sapiens (1-450) [Vh (Homo Sapiens Ighv3-23*01 (96.9%) -(Ighd) -Ighj4*01 (85.7%), Q120>R (113), Cdr-Imgt [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, G1V29 Ch2 A84.4 (Ch1 K120 (218) (122-219), Hinge 1-15 (220-234), Ch2 G1V29 Ch2 N84.4>A (301) (235-344), Ch3 D12 (360), L14 (362) (345-449), Chs K2>Del (450)) (122-450)], (224-214')-Disulfide With Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (94.7%) -Igkj4*01 (91.7%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; Dimer (230-230'':233-233'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1 Lacking The Glutamine Synthetase (Gs-Ko) Gene, Non-Glycosylated
Diffuse Large B-Cell Lymphoma
Immunitas TherapeuticsP1/2CC (43)
Jwcar239
Diffuse Large B-Cell Lymphoma
Peking University Cancer Hospital & InstituteP1CC (43)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Diffuse Large B-Cell Lymphoma
City of Hope Medical CenterP1CC (43)
L-Methionyl-Interleukin 15 (Human, Non-Glycosylated), Produced In Escherichia Coli, Substituted On An Average Of One Site Among N2 Of Met1 And/Or N6 Of Lysyl Residues With 4-(.Alpha.-Methylpoly(Oxyethylene)-.Omega.-Oxy)Butanoyl Groups (~40 Kda Each)
Diffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer CenterP1CC (43)
ly4584180
Diffuse Large B-Cell Lymphoma
Eli Lilly and CompanyP1CC (43)
mt-2111
Diffuse Large B-Cell Lymphoma
Tanabe Pharma CorporationP1/2CC (43)
P-Cd19Cd20-Allo1
Diffuse Large B-Cell Lymphoma
Poseida Therapeutics, Inc.P1CC (43)
Rimiducid
Diffuse Large B-Cell Lymphoma
Poseida Therapeutics, Inc.P1CC (43)
Sgr-1505
Diffuse Large B-Cell Lymphoma
Schrödinger, Inc.P1CC (43)
Tegavivint
Diffuse Large B-Cell Lymphoma
Lapo AlinariP1CC (43)
Tulmimetostat
Diffuse Large B-Cell Lymphoma
Novartis PharmaceuticalsP1/2CC (43)
Ub-Vv111
Diffuse Large B-Cell Lymphoma
Umoja BiopharmaP1CC (43)
Vancomycin
Diffuse Large B-Cell Lymphoma
Abramson Cancer Center at Penn MedicineP1CC (43)
Vnx-101
Diffuse Large B-Cell Lymphoma
Vironexis Biotherapeutics Inc.P1/2CC (43)
Duvelisib
Diffuse Large B-Cell Lymphoma
Ruijin HospitalP1CC (42)
kt-413
Diffuse Large B-Cell Lymphoma
Kymera Therapeutics, Inc.P1CC (42)
Prgn-3007
Diffuse Large B-Cell Lymphoma
H. Lee Moffitt Cancer Center and Research InstituteP1CC (42)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Diffuse Large B-Cell Lymphoma
Nurix Therapeutics, Inc.P1CC (41)
bbt369
Diffuse Large B-Cell Lymphoma
Regeneron PharmaceuticalsP1CC (41)
Btk-In-24
Diffuse Large B-Cell Lymphoma
Nurix Therapeutics, Inc.P1CC (41)
cd19.20.22 car t cells
Diffuse Large B-Cell Lymphoma
University of Maryland, BaltimoreP1CC (41)
cs08399
Diffuse Large B-Cell Lymphoma
Chipscreen Biosciences, Ltd.P1CC (41)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer
Diffuse Large B-Cell Lymphoma
Northside Hospital, Inc.P1CC (41)
ksv01
Diffuse Large B-Cell Lymphoma
TCRx Therapeutics Co.LtdP1CC (41)
Kur-502
Diffuse Large B-Cell Lymphoma
Athenex, Inc.P1CC (41)
Ltz-301
Diffuse Large B-Cell Lymphoma
LTZ Therapeutics, Inc.P1CC (41)
ly4152199 - iv
Diffuse Large B-Cell Lymphoma
Eli Lilly and CompanyP1CC (41)
Mivavotinib
Diffuse Large B-Cell Lymphoma
Calithera Biosciences, IncP2CC (41)
PF-08046044
Diffuse Large B-Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
pf-08046045
Diffuse Large B-Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Sgn-35
Diffuse Large B-Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Synkir-310
Diffuse Large B-Cell Lymphoma
Verismo TherapeuticsP1CC (41)
Wztl002-1
Diffuse Large B-Cell Lymphoma
Malaghan Institute of Medical ResearchP1CC (41)
Zelebrudomide
Diffuse Large B-Cell Lymphoma
Nurix Therapeutics, Inc.P1CC (41)
Showing 151 to 200 of 253 assets
PreviousPage 4 of 6Next